CVS Health (CVS) closed the latest trading day at $68.87, indicating a -1.87% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.

The stock's fall snapped a three-day winning streak.

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $74.12, accompanied by ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked ...

LITTLE ROCK, Ark. (KAIT/KARK) – An Arkansas bill aims to prevent pharmacy benefit managers from owning pharmacies. According ...

The Dow, S&P 500, and Nasdaq fell Tuesday, as the stock market's morning rally evaporated amid uncertainty around President Donald Trump's tariffs.

Health insurance stocks extended Monday’s gains into Tuesday after Medicare regulators finalized stronger-than-expected 2026 ...

CVS is shaking up its management ranks as newly installed CEO David Joyner tries to put his stamp on the health-care ...

CVS Pharmacy became the first and only national chain drug retailer to stop selling cigarettes and tobacco products, setting ...

Get these great CVS offers on Wednesday, April 9 on Maybelline New York liquid lipstick, Giorgio Armani perfume, Allergy ...